FDA Scientists Oppose Broad Peptide Injection Use, Clashing with Health Secretary Robert F. Kennedy Jr.'s Freedom‑to‑Experiment Stance

FDA scientists have issued recommendations opposing broad use of certain peptide injections. The advisory cautions that widespread application may pose health risks. The FDA scientists have issued recommendations opposing broad use of certain peptide

injections. The advisory cautions that widespread application may pose health risks. The scientists' stance reflects concerns over safety and efficacy. Health Secretary Robert F. Kennedy Jr. argues that individuals should be free to experiment with these treatments.

Kennedy’s position contrasts with the agency’s scientific advice. The disagreement highlights tension between regulatory caution and personal liberty. The issue could shape future FDA policy on experimental therapies. Stakeholders will monitor how the

administration resolves the clash.